PMID: 8943064Nov 26, 1996Paper

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

Proceedings of the National Academy of Sciences of the United States of America
P D KesslerB J Byrne

Abstract

Somatic gene therapy has been proposed as a means to achieve systemic delivery of therapeutic proteins. However, there is limited evidence that current methods of gene delivery can practically achieve this goal. In this study, we demonstrate that, following a single intramuscular administration of a recombinant adeno-associated virus (rAAV) vector containing the beta-galactosidase (AAV-lacZ) gene into adult BALB/c mice, protein expression was detected in myofibers for at least 32 weeks. A single intramuscular administration of an AAV vector containing a gene for human erythropoietin (AAV-Epo) into mice resulted in dose-dependent secretion of erythropoietin and corresponding increases in red blood cell production that persisted for up to 40 weeks. Primary human myotubes transduced in vitro with the AAV-Epo vector also showed dose-dependent production of Epo. These results demonstrate that rAAV vectors are able to transduce skeletal muscle and are capable of achieving sustained expression and systemic delivery of a therapeutic protein following a single intramuscular administration. Gene therapy using AAV vectors may provide a practical strategy for the treatment of inherited and acquired protein deficiencies.

References

Mar 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·M WiglerL Chasin
Jul 1, 1977·The Journal of General Virology·F L GrahamR Nairn
Jan 1, 1992·Current Topics in Microbiology and Immunology·N Muzyczka
Sep 1, 1992·American Journal of Respiratory Cell and Molecular Biology·T R FlotteB J Carter
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S N Yao, K Kurachi
Aug 1, 1992·The Journal of Clinical Investigation·L D Stratford-PerricaudetP Briand
Mar 23, 1990·Science·J A WolffP L Felgner
Sep 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·H M Blau, C Webster
Dec 7, 1995·The New England Journal of Medicine·H M Blau, M L Springer
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·T R FlotteB J Carter
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·W R OsborneA W Clowes
Sep 28, 1995·The New England Journal of Medicine·J M Leiden
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Mar 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·K I Berns, R M Linden
May 9, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E DowtyJ A Wolff
Nov 1, 1994·American Journal of Respiratory Cell and Molecular Biology·T R FlotteP L Zeitlin
Nov 22, 1994·Proceedings of the National Academy of Sciences of the United States of America·S K TripathyJ M Leiden
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·D W RussellI E Alexander
Aug 1, 1993·Trends in Genetics : TIG·H M BlauG K Pavlath
May 1, 1996·Human Molecular Genetics·R R AliS S Bhattacharya

❮ Previous
Next ❯

Citations

Feb 19, 2000·Microscopy Research and Technique·D Hartigan-O'Connor, J S Chamberlain
Mar 30, 2000·The Journal of Gene Medicine·R O Snyder
Mar 30, 2000·The Journal of Gene Medicine·O L KonY C Long
Feb 24, 2001·The Journal of Gene Medicine·C R O'RiordanS C Wadsworth
Dec 5, 2002·International Journal of Hematology·Katherine A High
Aug 8, 2007·Applied Microbiology and Biotechnology·Alejandro NegreteRobert M Kotin
Oct 1, 2013·Molecular Biology Reports·Rilun LiChunmin Liang
Dec 21, 2000·Current Atherosclerosis Reports·D J Rader, U J Tietge
Jul 5, 2008·Clinical Reviews in Allergy & Immunology·Christian Mueller, Terence R Flotte
Nov 18, 1985·FEBS Letters·S K GeorgeS R Bloom
May 1, 1992·Molecular and Cellular Endocrinology·H C FehmannB Göke
Nov 8, 2001·European Journal of Pharmacology·M Pohl, J Braz
Sep 13, 2003·Fertility and Sterility·Gaurang S Daftary, Hugh S Taylor
Feb 1, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Wenyin ShiDietmar W Siemann
Feb 9, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·E ShinyaD Klatzmann
Nov 20, 1998·Current Opinion in Biotechnology·J E Rabinowitz, J Samulski
Aug 5, 1998·Current Opinion in Genetics & Development·D J Marshall, J M Leiden
Sep 11, 2002·Neuromuscular Disorders : NMD·G DicksonS A Fabb
Mar 15, 2001·Critical Reviews in Oncology/hematology·H H Sedlacek
Jan 20, 2000·Trends in Cardiovascular Medicine·K P Ponder
Oct 13, 2000·Progress in Retinal and Eye Research·W W Hauswirth, A S Lewin
Jan 15, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Carmen S PedenRonald J Mandel
May 8, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Alice ToromanoffCaroline Le Guiner
Nov 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Louise R Rodino-KlapacLouis G Chicoine
Jan 28, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cathryn S MahBarry J Byrne
Dec 2, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lauren E Mays, James M Wilson
Jul 21, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Zheng FanWilliam Powers
Nov 24, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ping-Jie XiaoR Jude Samulski
Jan 9, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jason C SteelJohn C Morris
Mar 1, 2005·Nature Biotechnology·Zhong WangXiao Xiao
May 20, 1998·Nature Genetics·C H MiaoM A Kay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.